Showing results (421-430 of 1,946) with videos related to
Sort By:
Pageof 195
RMD Open|November 10, 2023
Biomechanics in the onset and severity of spondyloarthritis: a force to be reckoned withPriyanka Iyer, Mark Hwang, Lauren Ridley, et al.RMD Open|November 9, 2023
Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohortDaniel Montes, Cassondra A Hulshizer, Elena Myasoedova, et al.RMD Open|November 9, 2023
Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based studyOh Chan Kwon, Kyungdo Han, Min-Chan ParkRMD Open|November 9, 2023
Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2-5 and MAXIMISE studiesRenaud Felten, Laura Widawski, Lionel Spielmann, et al.RMD Open|November 9, 2023
Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trialVinod Chandran, Vladislav A Malkov, Kaori L Ito, et al.RMD Open|October 5, 2023
Effect of research participation versus usual clinical care in patients with rheumatic and musculoskeletal disorders: a prospective cohort studyElisabeth Ginnerup-Nielsen, Robin Christensen, Henning Bliddal, et al.RMD Open|September 29, 2023
Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatmentMarta Novella-Navarro, JoséLuis Cabrera-Alarcón, Natalia López-Juanes, et al.RMD Open|September 21, 2023
Spontaneous resolution of acute gout: mechanisms and therapeutic targetsMeiling Shi, Jiao Luo, Liting Ding, et al.RMD Open|September 23, 2024
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studiesM Elaine Husni, Philip J Mease, Joseph F Merola, et al.RMD Open|October 7, 2024
Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMIDLaura Y L Kummer, Laura Fernández Blanco, Christine Kreher, et al.Pageof 195